Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peck-Radosavljevic, M.
Right arrow Articles by Gangl, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peck-Radosavljevic, M.
Right arrow Articles by Gangl, A.
Related Collections
Right arrow Clinical Trials and Observations
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 95 No. 3 (February 1), 2000: pp. 795-801

Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production

Markus Peck-Radosavljevic, Martina Wichlas, Johannes Zacherl, Gabriele Stiegler, Petra Stohlawetz, Michael Fuchsjäger, Anna Kreil, Sylvia Metz-Schimmerl, Simon Panzer, Rudolf Steininger, Ferdinand Mühlbacher, Peter Ferenci, Johann Pidlich, and Alfred Gangl

From the Departments of Gastroenterology and Hepatology, Transplant Surgery, Blood Group Serology and Transfusion Medicine, and Radiology, University of Vienna, Austria.

Thrombopoietin (TPO) deficiency has been proposed as an important etiologic factor for thrombocytopenia in advanced-stage liver disease. To clarify the contributions of platelet production, platelet consumption, coagulation activation, and splenic sequestration to thrombocytopenia in liver disease, we studied TPO serum levels and markers of platelet production, platelet activation, and coagulation activation before and 14 days after orthotopic liver transplantation (OLT) in 18 patients with advanced liver cirrhosis. Thrombocytopenia before transplantation occurred with low-normal serum levels of TPO, normal levels of platelet and coagulation activation markers, and no increase in bone marrow production of platelets. TPO serum levels increased significantly on the first day after OLT, preceding the increase of reticulated platelets by 3 days and peripheral platelets by 5 days. Normalization of the peripheral platelet count occurred in most patients within 14 days of OLT, irrespective of the change in spleen size assessed by computed tomography volumetry. Normalization of platelet counts was not hampered by a certain degree of platelet activation observed during the steepest increase in the peripheral platelet count. Bone marrow production of platelets increased significantly within 2 weeks of transplantation. Low TPO serum levels with low platelet counts and without platelet consumption suggests low TPO production in end-stage liver disease. The rapid increase in TPO serum levels after transplantation induces an increase in the bone marrow production of platelets. Decreased TPO production in the cirrhotic liver is an important etiologic factor for thrombocytopenia in liver disease that is rapidly reversed by transplantation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
D. J. Kuter
New thrombopoietic growth factors
Blood, June 1, 2007; 109(11): 4607 - 4616.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Schmid, A Kreil, W Jessner, M Homoncik, C Datz, A Gangl, P Ferenci, and M Peck-Radosavljevic
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon {alpha} mono and combination therapy regimens
Gut, July 1, 2005; 54(7): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. J. Kuter and C. G. Begley
Recombinant human thrombopoietin: basic biology and evaluation of clinical studies
Blood, November 15, 2002; 100(10): 3457 - 3469.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
J. Hambleton, L. L. Leung, and M. Levi
Coagulation: Consultative Hemostasis
Hematology, January 1, 2002; 2002(1): 335 - 352.
[Abstract] [Full Text]


Home page
BloodHome page
A. Kaser, G. Brandacher, W. Steurer, S. Kaser, F. A. Offner, H. Zoller, I. Theurl, W. Widder, C. Molnar, O. Ludwiczek, et al.
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Blood, November 1, 2001; 98(9): 2720 - 2725.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. E. DREWS and S. E. WEINBERGER
Thrombocytopenic Disorders in Critically Ill Patients
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 347 - 351.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020